1. Foo, Jia Nee, Chew, Elaine Guo Yan, Chung, Sun Ju, Liu, Jianjun, Tan, Eng-King. . Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study. In JAMA neurology, 77, 746-754. doi:10.1001/jamaneurol.2020.0428. https://pubmed.ncbi.nlm.nih.gov/32310270/
2. Sun, Lidong, Bai, Donghao, Lin, Maoguang, Wang, Fengzhen, Jin, Shangwu. 2021. miR-96 Inhibits SV2C to Promote Depression-Like Behavior and Memory Disorders in Mice. In Frontiers in behavioral neuroscience, 14, 575345. doi:10.3389/fnbeh.2020.575345. https://pubmed.ncbi.nlm.nih.gov/33815074/
3. Yang, Meiyuan, Li, Yaobin, Hu, Lei, Zhang, Lixia, Zhu, Gaochun. 2018. Lead exposure inhibits expression of SV2C through NRSF. In Toxicology, 398-399, 23-30. doi:10.1016/j.tox.2018.02.009. https://pubmed.ncbi.nlm.nih.gov/29505838/
4. Dunn, Amy R, Stout, Kristen A, Ozawa, Minagi, Caudle, W Michael, Miller, Gary W. 2017. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. In Proceedings of the National Academy of Sciences of the United States of America, 114, E2253-E2262. doi:10.1073/pnas.1616892114. https://pubmed.ncbi.nlm.nih.gov/28246328/
5. Dunn, Amy R, Hoffman, Carlie A, Stout, Kristen A, Dhamsania, Rohan K, Miller, Gary W. 2017. Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain. In Brain research, 1702, 85-95. doi:10.1016/j.brainres.2017.12.029. https://pubmed.ncbi.nlm.nih.gov/29274878/
6. Ramsey, Timothy L, Liu, Qian, Massey, Bill W, Brennan, Mark D. 2013. Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study. In Schizophrenia research, 149, 21-5. doi:10.1016/j.schres.2013.07.008. https://pubmed.ncbi.nlm.nih.gov/23886675/
智鼠故事 
